Targeted Messages for Different Demographics

 Race/Ethnicity

  • COVID-19 vaccines have been studied in clinical trials with large and diverse groups of people of various ages, races and ethnicities.

  • The vaccine development process is heavily regulated and transparent. For COVID-19, a diverse group of doctors and public health practitioners were assembled to ensure that the vaccine was safe and effective across racial groups.

  • Focus on making decisions that are best for you and your family, following fact-based, trusted information about vaccine safety and efficacy, including links to trusted sources of information (e.g., CDC, WHO, academic institutions).

  • Messaging from personal doctors and other health care providers are typically among the most trusted sources for Black/African Americans, e.g., Black/African Americans may also be more responsive to messaging from faith-based leaders.

  • Messaging from medical experts and community health providers are the most trusted sources for Hispanic/Latinos. Hispanic/Latinos may also be more receptive to messages from their inner circle such as neighbors, their mayor, and people they follow on social media

Age

  • COVID-19 vaccines have been studied in clinical trials with large and diverse groups of people, of various ages, races, and ethnicities.

  • Older adults may be more motivated to reduce their own risk for severe illness or death.

  • Young adults may be less concerned about their own health but more motivated to prevent transmitting the infection to older family members.

  • There is no evidence suggesting that fertility problems are a side effect of any of the COVID-19 vaccines.1 People who are trying to become pregnant now or who plan to try in the future may receive the COVID-19 vaccine. (See ACOG’s practice advisory2 and CDC recommendations on vaccination of pregnant people.3

  • You may encourage adults age 65 and older to receive an additional updated (bivalent) vaccine dose at least four month after their initial updated (bivalent) vaccine dose for additional protection.

    1. Aharon D, Lederman M, Ghofranian A, et al. In vitro fertilization and early pregnancy outcomes after coronavirus disease 2019 (COVID-19) vaccination. Obstetrics & Gynecology. January 25, 2022. doi: 10.1097/AOG.0000000000004713.

    2. The American College of Obstetricians and Gynecologists. Practice Advisory: COVID-19 Vaccination Considerations for Obstetric-Gynecologic Care. September 25, 2023. Available at: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care.

    3. Centers for Disease Control and Prevention (CDC). New CDC Data: COVID-19 Vaccination Safe for Pregnant People. August 11, 2021. Available at: https://www.cdc.gov/media/releases/2021/s0811-vaccine-safe-pregnant.html.Description text goes here

RWJBH Webinar: Fears, Hesitation & Access: What the Black Community Needs to Know About the COVID-19 Vaccine